September 30, 2026
Uncategorized

Shaily Engineering gains 4% on ₹423 cr order; UBS’s top 2026 midcap pick (Soban News)

UBS, in its Feb 15 report, named Shaily Engineering as its top midcap idea for 2026, citing a likely growth step-up driven by opportunities in generic semaglutide delivery devices​UBS, in its Feb 15 report, named Shaily Engineering as its top midcap idea for 2026, citing a likely growth step-up driven by opportunities in generic semaglutide delivery devices ​Latest News [ SOBAN NEWS: International and National ]

Related posts

Gold slips to over one-month low as West Asia tensions lift oil prices (Soban News)

News-Soban-Admin

10 pharma firms launch semaglutide in India; Nomura sees ₹12k-cr mkt (Soban News)

News-Soban-Admin

Six foreign universities commit ₹1,000 crore scholarship pool for India (Soban News)

News-Soban-Admin

Leave a Comment